These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28606595)

  • 1. A Multisite Retrospective Study Evaluating the Implementation of the Pasero Opioid-Induced Sedation Scale (POSS) and Its Effect on Patient Safety Outcomes.
    Davis C; Geik C; Arthur K; Fuller J; Johnston E; Levitt F; Leung E; McCart G; McMichael D; Painter J; Staublin T; Walroth T
    Pain Manag Nurs; 2017 Aug; 18(4):193-201. PubMed ID: 28606595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the Pasero Opioid-induced Sedation Scale (POSS) in Pediatric Patients.
    Quinlan-Colwell A; Thear G; Miller-Baldwin E; Smith A
    J Pediatr Nurs; 2017; 33():83-87. PubMed ID: 28209260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of naloxone use in hospitalized patients.
    Yung L; Lee KC; Hsu C; Furnish T; Atayee RS
    Postgrad Med; 2017 Jan; 129(1):40-45. PubMed ID: 27858510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Literature Review: Assessment of Opioid-related Sedation and the Pasero Opioid Sedation Scale.
    Hall KR; Stanley AY
    J Perianesth Nurs; 2019 Feb; 34(1):132-142. PubMed ID: 29709268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of required sedation assessment in nursing workflow to address naloxone utilization.
    Hardison E; Bloomer A; Wally MK; McArthur E; Hsu JR; Bear S; Jarrett S; Roomian T; Sullivan DM; Wold K; Yu Z; Odum S; Seymour RB
    J Opioid Manag; 2023; 19(3):247-255. PubMed ID: 37145927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Findings of a Naloxone Database and its Utilization to Improve Safety and Education in a Tertiary Care Medical Center.
    Rosenfeld DM; Betcher JA; Shah RA; Chang YH; Cheng MR; Cubillo EI; Griffin JM; Trentman TL
    Pain Pract; 2016 Mar; 16(3):327-33. PubMed ID: 25564757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of solutions to reduce opioid-induced oversedation and respiratory depression.
    Meisenberg B; Ness J; Rao S; Rhule J; Ley C
    Am J Health Syst Pharm; 2017 Feb; 74(3):162-169. PubMed ID: 27993764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of Opioid-Induced Ventilatory Depression Using Low-Dose Naloxone (0.04 mg): a Case Series.
    Kim HK; Nelson LS
    J Med Toxicol; 2016 Mar; 12(1):107-10. PubMed ID: 26289651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Delayed Postoperative Respiratory Depression Assessed from Naloxone Administration.
    Weingarten TN; Herasevich V; McGlinch MC; Beatty NC; Christensen ED; Hannifan SK; Koenig AE; Klanke J; Zhu X; Gali B; Schroeder DR; Sprung J
    Anesth Analg; 2015 Aug; 121(2):422-9. PubMed ID: 25993390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain, Agitation, and Delirium Guidelines: Interprofessional Perspectives to Translate the Evidence.
    Jablonski J; Gray J; Miano T; Redline G; Teufel H; Collins T; Pascual-Lopez J; Sylvia M; Martin ND
    Dimens Crit Care Nurs; 2017; 36(3):164-173. PubMed ID: 28375992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid-Induced Sedation and Respiratory Depression: Are Sedation Scales Enough to Prevent Adverse Drug Events Postoperatively?
    Dunwoody DR; Jungquist CR
    Pain Manag Nurs; 2020 Feb; 21(1):110-119. PubMed ID: 31103506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a standardized sedation assessment for opioid administration in the post anesthesia care unit.
    Kobelt P; Burke K; Renker P
    Pain Manag Nurs; 2014 Sep; 15(3):672-81. PubMed ID: 24461253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of selected sedation scales for reporting opioid-induced sedation assessment.
    Nisbet AT; Mooney-Cotter F
    Pain Manag Nurs; 2009 Sep; 10(3):154-64. PubMed ID: 19706353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Instituting best practice for monitoring for opioid-induced advancing sedation in hospitalized patients.
    Jungquist CR; Pasero C; Tripoli NM; Gorodetsky R; Metersky M; Polomano RC
    Worldviews Evid Based Nurs; 2014 Dec; 11(6):350-60. PubMed ID: 25252100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring sedation in patients receiving opioids for pain management.
    Smith A; Farrington M; Matthews G
    J Nurs Care Qual; 2014; 29(4):345-53. PubMed ID: 24686040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose.
    Wampler DA; Molina DK; McManus J; Laws P; Manifold CA
    Prehosp Emerg Care; 2011; 15(3):320-4. PubMed ID: 21612385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the appropriateness of naloxone administration to patients receiving long-term opioid therapy.
    Facey C; Brooks D; Boland JW
    Hosp Pract (1995); 2016; 44(2):86-91. PubMed ID: 26837434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydromorphone Compared to Fentanyl in Patients Receiving Extracorporeal Membrane Oxygenation.
    Martin NJ; Peitz GJ; Olsen KM; Merritt HML
    ASAIO J; 2021 Apr; 67(4):443-448. PubMed ID: 33770000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk predictors of opioid-induced critical respiratory events in children: naloxone use as a quality measure of opioid safety.
    Chidambaran V; Olbrecht V; Hossain M; Sadhasivam S; Rose J; Meyer MJ
    Pain Med; 2014 Dec; 15(12):2139-49. PubMed ID: 25319840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of enteral naloxone for the reversal of opiate-induced constipation in the intensive care unit.
    Arpino PA; Thompson BT
    J Clin Pharm Ther; 2009 Apr; 34(2):171-5. PubMed ID: 19250137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.